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Abstract
Research on exposure to animals and risk of type 1 diabetes (T1D) has had
conflicting results with some researchers finding that animal exposure reduces the risk of
T1D and others finding no association between animal exposure and T1D. Previously
conducted studies on the association between animal exposure and T1D are casecontrol studies that have been limited by recall bias. The purpose of this study is to
investigate the association between early life animal exposure and the risk of persistent,
confirmed islet autoantibodies (IA) and T1D diagnosis among an eligible cohort of
genetically high T1D risk participants enrolled in the international prospective cohort
study, The Environmental Determinants of Diabetes in the Young (TEDDY). It is
hypothesized that children who are exposed to animals in early life will have a lower risk
of developing IA and T1D than children who are not exposed to animals in early life.
A total of 7,432 TEDDY participants were included in the study. The associations
between early life animal exposure and the outcomes of interest were explored using
Cox proportional hazards models. In order to control for confounding, a propensity score
analysis was applied by three different methods: adjustment for the propensity score
variable in the Cox proportional hazards model, stratification on propensity score groups,
and propensity score pair matching.
Early life animal exposure was not associated with diabetes autoimmunity or T1D
onset in this genetically high T1D risk population. These findings were consistent across
all three propensity score analysis methods and when directly adjusting for HLA type.
The hypothesis that children who are exposed to animals in early life will have a lower
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risk of developing IA and T1D than children who are not exposed to animals in early life
is not supported by this study.
The results of this study suggest that there is no association between early life
animal exposure and development of T1D. Performing this analysis again after longer
follow-up has been completed for the study population is recommended as it may
elucidate the effect of animal exposure on T1D and IA risk. Further studies are also
needed on animal exposure and T1D in different types of environments (e.g., high
residential density) and the effect of different types of animal exposures (e.g., species,
duration) on T1D and IA risk. Additionally, studies on differences in perceptions of pets
across countries could also aid the interpretation of studies on animal exposure and
health outcomes.

vii

Introduction
Background
Type 1 diabetes (T1D) is a chronic disease characterized by the autoimmune
destruction of pancreatic beta-cells leading to absolute insulin deficiency (1). Insulin is a
hormone produced by the pancreatic beta-cells to lower the glucose level in the body
and is essential for survival. Uncontrolled glucose levels can result in complications such
as diabetic ketoacidosis, retinopathy, neuropathy, and nephropathy (1). There is
currently no standard practice available to prevent or cure T1D. The standard treatment
for T1D is multiple daily injections of insulin through a pump or needle and patient selfmonitoring of blood glucose with the challenging goal of obtaining and maintaining
glycemic control. The onset of T1D is known to occur early in life with three-quarters of
all individuals with T1D diagnosed under the age of 18 years (1).
The incidence of T1D has increased over time. A study assessing T1D incidence
trends among Colorado youth enrolled in the Colorado IDDM Registry and SEARCH for
Diabetes in Youth Study reported an annual increase in T1D incidence of 2.3% (95% CI:
1.6-3.1) from 1978 to 2004 (2). The EURODIAB study, an international collaborative
effort consisting of 20 population-based registries across 17 countries, reported a 3.2%
(95% CI: 2.7-3.7) annual increase in T1D incidence from 1989 to 1998 and a 3.9% (95%
CI: 3.6-4.2) annual increase from 1989 to 2003 (3, 4). The DIAMOND project, an
international collaborative effort across 57 countries, reported an annual increase of
2.4% (95% CI=1.3-3.4) from 1990 to 1994 and an annual increase of 3.4% (95% CI: 2.74.3) from 1995 to 1999 (5). T1D incidence is predicted to continue to increase, with the
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incidence in children under 5 years of age predicted to double between 2005 and 2020
(4, 5).
Understanding why the incidence of T1D is increasing and what factors trigger
the chain of reactions that cause the body to attack its own pancreatic beta-cells are
among the many unanswered questions about T1D. Studies on the relationship between
genetic disposition and T1D have reported associations between several genes and T1D
risk, most notably human leukocyte antigens (HLA); however, less than 10% of
genetically susceptible individuals actually develop T1D (6, 7, 8). Additionally, the
pairwise concordance rate of monozygotic twins has been reported at 39% to 50% (9).
These findings imply that genetics alone is not responsible for T1D risk and
development. Reports of large T1D incidence variation across countries (5, 8), incidence
increases too rapid to be explained by shifts in genetic susceptibility (5, 10), and reduced
frequency of high risk HLA genotypes (11, 12) have led researchers to suspect that
environmental exposures play a significant role in disease incidence. Thus, the question
has been raised as to which environmental exposures play a role in triggering the
autoimmune response leading to the destruction of beta-cells in the pancreas and
development of T1D.
Interest in environmental exposures and autoimmune disease development is
rooted in the hygiene hypothesis, also known as the old friends hypothesis. The hygiene
hypothesis is the assumption that individuals who are not exposed to organisms early in
life that help to develop appropriate immunoregulation are more susceptible to
autoimmune diseases as the immunoregulation deficit is believed to potentially cause an
overreaction to later environmental exposures and attack important cells, such as the
beta-cells critical to insulin production (13). Environmental exposures assessed in
studies of the hygiene hypothesis and autoimmune disease development include
elements that could lead to earlier and more antigenic exposure in life such as the
2

number of individuals in the household, number of siblings, room sharing, social contact
(e.g., daycare, class size), geographical location (e.g., rural, urban), and animal contact.
Researcher Graham A. W. Rook has identified several critical organisms that
have an important contribution to immunoregulation and are relevant to chronic
autoimmune disorders. Specifically, Rook has proposed Helicobacter pylori, Salmonella,
and many species of helminths as protective against allergies, Hepatitis A virus and
Necator americanus as protective against asthma, and coxsackievirus B and rotavirus
as protective against T1D (13). These particular organisms were selected because they
were each abundant during mammalian evolution, are virtually absent from the present
environment, and have had therapeutic effects in animal models or human clinical trials
on chronic inflammatory disorders (13).
The hygiene hypothesis has been repeatedly supported in studies of
autoimmune diseases such as asthma and allergies (14, 15, 16). Strachan noted in his
10-year review of epidemiological literature on the hygiene hypothesis that the scientific
community has consistently found a higher prevalence of hay fever, eczema, skin prick
positivity, and allergen specific IgE among individuals raised in smaller, more affluent
families (15). Another example of evidence for the hygiene hypothesis is the casecontrol study conducted by Boneberger et al. to test the validity of the hygiene
hypothesis in regard to childhood asthma, which showed that daycare attendance (OR:
0.31, 95% CI: 0.10-0.94) and regular farm animal contact (OR: 0.38, 95% CI: 0.17-0.85)
in the first year of life had a statistically significant protective effect on childhood asthma
(16).
There is also evidence supporting a protective association between several of
the environmental exposures related to the hygiene hypothesis and risk of T1D,
including crowded living conditions, sharing a room, having older siblings, and social
contact with other children (17, 18); however, minimal research has been conducted on
3

the relationship between animal contact and T1D risk specifically. The few studies that
have assessed the relationship between animal contact and T1D risk have had
conflicting results and notable design flaws. Marshall et al. conducted a matched casecontrol study in Lancashire and Cumbria, United Kingdom to identify environmental risk
factors for T1D in children up to age 16 years (17). Marshall et al. reported a statistically
significant protective association (OR: 0.552, 95% CI: 0.309-0.987) between regular
contact with pets or animals and the risk of developing T1D (17). Radon et al. conducted
a case-control study in children age 6 to 16 years living in rural areas of Germany to
explore the relationship between exposure to farming environments and T1D (19).
Radon et al. reported no statistically significant associations related to regular contact
with farm animals, defined as contact at least once per week, in the first year of life (OR:
1.2, 95% CI: 0.5-2.7) nor during the second to sixth year of life (OR: 0.81, 95% CI: 0.411.6) (19).
The major limitation of the previously conducted studies on animal contact and
T1D is that exposure data was collected after T1D diagnosis, resulting in possible recall
bias. Recall bias could result in overestimation of the association away from the null due
to a systemic difference in the way that cases and controls recall the exposures of
interest. For example, individuals diagnosed with T1D may be more cognizant of all
environmental exposures and more likely to recall animal exposures than individuals
who have not been diagnosed with T1D. An additional limitation of these studies is a
possible lack of statistical power to detect weak effects due to sample size, as
specifically noted by Radon et al. (19). Another general challenge of case-control studies
is difficulty in selecting appropriate controls, which can result in selection bias and
distortion of the reported measure of association.
The Environmental Determinants of Diabetes in the Young (TEDDY) study is a
multinational prospective cohort study with the primary goal of identifying environmental
4

exposures that contribute to increased risk of the development of beta-cell autoimmunity
and T1D in genetically susceptible children from birth to 15 years of age (20). Among the
vast amount of data collected as a part of the study is the report of pet and animal
exposures by the primary caregivers of children followed in the study. The TEDDY study
offers an ideal body of data for studying the relationship between animal contact and
T1D risk as its study design allows for the collection of data on environmental exposures
prior to T1D diagnosis, thereby limiting recall bias. Exploring the potential association
between animal exposures and T1D without recall bias would greatly contribute to
existing scientific knowledge on the hygiene hypothesis and T1D development.
Another advantage of the cohort study design as opposed to the case-control
study design is that multiple outcomes can be evaluated in cohort studies. This will allow
for evaluation of both T1D diagnosis and pancreatic islet autoantibodies (IA), which are
highly predictive of T1D risk and can be assessed prior to T1D diagnosis (21). An
additional advantage of the TEDDY dataset is that it has a diverse international study
population, which will allow possible effect modifiers such as country of residence to be
evaluated and described. Data on possible confounders were also collected throughout
the study; therefore, possible confounders can be controlled for when investigating the
association between early life animal exposures and the risk of IA and T1D.

Study Objectives
In response to the minimal existing body of literature on the role of animal
exposures in T1D development, the study design limitations of the existing literature, and
the new possibilities and advantages offered by the TEDDY dataset, this study aims to
investigate the association between reported early life animal exposures and T1D
development, considering both persistent, confirmed IA and T1D diagnosis, among the
8,677 individuals enrolled in the prospective international TEDDY cohort between
5

September 2004 and February 2010. Specifically, this study aims to answer the
following questions:
1. Does the risk of developing IA differ between children who are exposed to
animals in early life and children who are not exposed to animals in early life?
2. Does the risk of developing T1D differ between children who are exposed to
animals in early life and children who are not exposed to animals in early life?

Study Hypotheses
It is hypothesized that children who are exposed to animals in early life will have
a lower risk of developing IA than children who are not exposed to animals in early life. It
is also hypothesized that children who are exposed to animals in early life will have a
lower risk of developing T1D than children who are not exposed to animals in early life.
These hypotheses are based on the assumption that animals increase a child’s
exposure to organisms that help to develop appropriate immunoregulation and that
children not exposed to organisms that help to develop appropriate immunoregulation
are more susceptible to experience an autoimmune overreaction triggering the
development of islet autoimmunity and T1D, as suggested by the hygiene hypothesis.
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Methods
Methods Overview
The Environmental Determinants of Diabetes in the Young (TEDDY) Study is an
international cohort study consisting of 8,677 participants at genetically high risk for type
1 diabetes (T1D) who were enrolled as newborns between September 2004 and
February 2010 and followed through the time of T1D diagnosis or age 15 years,
depending on the time point encountered first for each participant. An abundance of data
on environmental exposures that may contribute to increased risk of the development of
IA and T1D are collected for each participant throughout study follow-up. Early life data
and outcomes data on the TEDDY cohort will be used for the proposed study.
The proposed observational study aims to investigate the association between
early life animal exposure and development of IA and T1D using an eligible cohort of
participants enrolled in the TEDDY study. Early life is considered to be prior to 9 months
of age for the purposes of this analysis. This particular time period was selected,
because the 9-month study visit is the first study visit at which animal exposure data is
collected from TEDDY participants. Data on potential confounding variables will also be
limited to early life exposure, before age 9 months. Propensity scores were incorporated
into the analysis methodology to compare outcome risk between participants with similar
animal exposure propensity scores and differing actual animal exposure status in order
to control for confounding in the evaluation of the association between early life animal
exposure and risk of IA and T1D. The propensity score calculated for each participant
represents the predicted probability of early life animal exposure for that participant
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based on other individual characteristics. Details on the study population, variables of
interest, data preparation, and analysis methodology follow.

TEDDY Study Overview
TEDDY participants are recruited by six U.S. and European clinical centers
located in Washington, Colorado, Georgia/Florida, Finland, Sweden, and Germany. The
TEDDY data coordinating center is located at the University of South Florida in Tampa,
Florida. The TEDDY study population to date includes children up to age 8 years who
were enrolled in the TEDDY study during the screening period from September 2004 to
February 2010. Newborns younger than 4.5 months of age who have high-risk HLA
alleles in the general population (GP) or who have a first degree relative (FDR) with T1D
were eligible for enrollment in the TEDDY cohort. The HLA alleles listed in Table 1 were
considered high-risk alleles for the purposes of study screening. Newborns with an
illness or birth defect that would prevent long term follow-up or would involve use of a
treatment that may alter the natural history of diabetes were not eligible for enrollment.

Table 1: Eligible HLA Haplotypes for TEDDY Study Enrollment
HLA Haplotypes
HLA Haplotype Category
DR4*030X/0302*DR3*0501/0201
DQ8/2
DR4*030X/0302*DR4*030X/0302
DQ8/8
DR4*030X/0302*DR4*030X/020X
DQ8/8
DR4*030X/0302*DR8*0401/0402
DQ8/4
DR4*030X/0302*DR1*0101/0501
FDR
DR4*030X/0302*DR13*0102/0604
FDR
DR4*030X/0302*DR4*030X/0304
DQ8/8
DR4*030X/0302*DR9*030X/0303
FDR
DR3*0501/0201*DR3*0501/0201
DQ2/2
DR3*0501/0201*DR9*030X/0303
FDR

A total of 424,788 newborns were screened for the TEDDY study. Study
screening involved HLA testing for HLA class II genes DRB1, DQA1, and DQB1. Parent
8

or primary caretaker consent was obtained from each potential participant prior to
screening. Among the 418,367 GP newborns screened, 20,152 (4.8%) were eligible for
enrollment. Among the 6,421 FDR newborns screened, 1,437 (22.4%) were eligible for
enrollment. A separate consent was obtained from the parents or primary caretakers of
eligible newborns prior to study enrollment. A total of 8,677 participants were enrolled in
TEDDY as of February 2010.
Newborns enrolled in the TEDDY study are followed until 15 years of age or T1D
diagnosis, depending on which is encountered first. Follow-up study visits for exposure
data collection occur quarterly (every three months) until age 4 years. The follow-up
study visit schedule then continues biannually for participants who are negative for IA
and quarterly for participants who are persistently positive for IA until age 15 years.

Scope of Proposed Analysis: Animal Exposures, T1D, and Autoimmunity
The purpose of this analysis is to explore the relationship between reported early
life animal exposure reported at the 9-month study visit and the outcomes persistent,
confirmed islet autoimmunity and T1D diagnosis among those eligible enrolled in
TEDDY cohort (N=8,677) during the screening period. The exposure of interest is any
exposure to animals prior to the 9-month study visit. Outcomes of interest include
persistent, confirmed IA and T1D diagnosis. Data cleaning and statistical analyses were
conducted using SAS version 9.2.

Inclusion Criteria and Exclusion Criteria for Analysis
Inclusion Criteria:
1. Participant was enrolled in the TEDDY study between September 2004 and
February 2010.
2. Participant has a 9-month study visit record.
9

Exclusion Criteria:
1. HLA results are pending or HLA results indicate that the participant does not
have a high risk allele.
2. Participant was diagnosed with T1D prior to the 9-month study visit.
3. Participant had persistent, confirmed IA prior to the 9-month study visit.

Of the 8,677 participants in the TEDDY cohort, 7,604 participants had a 9-month
study visit record. Differences between participants who withdrew from the TEDDY study
within one year of enrollment and those who remained in the TEDDY study have been
previously described by Johnson et al. (22). Significant predictors of early withdrawal
identified by Johnson et al. include country of residence, young maternal age, no father
participation, and female gender. Exclusions were performed on the 7,604 participants
who met the defined inclusion criteria in the order listed above. As outlined in Figure 1,
135 participants were excluded due to pending or ineligible HLA results and 37
participants were excluded due to having persistent, confirmed IA prior to the 9-month
visit. The final study population for the analysis included 7,432 participants.

Animal Exposure Classification
History of animal exposures was collected from the primary caregiver at the 9month follow-up visit using a questionnaire. Questions 15 and 16 on the questionnaire
focused on animal exposures. Question 15 asked if there were any animals or pets in
the TEDDY child’s house with the option to select “Yes” or “No” in response. If the
caretaker completing the questionnaire indicated that there were animals or pets in the
TEDDY child’s house, the caretaker was also prompted to indicate the type of pet in the
TEDDY child’s house and the number of pets in the TEDDY child’s house. Question 16
asked if the TEDDY child lives on a farm with animals or if there were animals that lived
10

outside of the child’s house with the option to select “Yes” or “No” in response.
Additionally, the caretaker was prompted to indicate the type of animals that live outside
of the TEDDY child’s house. The full 9-month questionnaire which includes the
described questions on animal exposures is provided in Appendix 2.
The animal exposure data collected on the 9-month questionnaire were used to
create a variable indicating whether or not each participant had any exposure to animals,
regardless of whether the animal lived inside or outside the house, prior to the 9-month
visit. This variable was created as a binary variable with “1” indicating that the participant
was exposed to at least one animal as of the 9-month visit and “0” indicating that the
participant was not exposed to any animals as of the 9-month visit. A participant was
coded as “1” for this variable if the caretaker answered “Yes” to question 15, answered
“Yes” to question 16, or selected a type of indoor or outdoor animal. Otherwise, the
participant was coded as “0”.

Outcome Classification
The study analysis was performed for two separate outcomes: persistent,
confirmed IA and T1D. Since the maximum age of the study population is only 8 years, it
is expected that the number of participants diagnosed with T1D may not be large
enough to make appropriate association conclusions. Islet autoimmunity is highly
predictive of T1D and usually occurs prior to T1D diagnosis (21); therefore, it is expected
that analyzing the relationship between animal exposures and persistent, confirmed IA
will allow for more confident conclusions at this stage.
A power analysis was conducted using the program Power and Sample Size
(PASS) 12 by the Lakatos method. For the outcome IA, it is estimated that early life
animal exposure will need to be associated with IA at a hazard ratio (HR) of 1.4 or
greater in order for the study to have 80% power (Table 2), which would allow the study
11

to have an 80% probability of rejecting the null hypothesis when it is false. For the
outcome T1D, it is estimated that early life animal exposure will need to be associated
with T1D at a HR of 1.65 in order for the study to have 80% power (Table 3).

Participants in the TEDDY cohort
(N=8677)
1073 participants did not have a 9-month
visit record
Participants in the TEDDY cohort with
a 9-month visit record (N=7604)

135 participants did not have high risk
HLA alleles or had pending test results

0 participants were diagnosed with T1D
prior to the 9 month visit

37 participants had persistent,
confirmed IA prior to the 9 month visit

Final Study Population
(N=7432)

Figure 1: Eligibility Flowchart

Table 2: Power for IA Outcome, Alpha=0.05, N=8,677, 50% Exposed, 4 Years Accrual,
Follow-up to Age 8 Years, 14% Loss, 5% Conversion
HR
1.30
1.35
1.40
1.45
1.50

Power
0.62
0.75
0.85
0.91
0.96
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Table 3: Power for T1D Outcome, Alpha=0.05, N=8,677, 50% Exposed, 4 Years
Accrual, Follow-up to Age 8 Years, 14% Loss, 2% Conversion
HR
1.60
1.65
1.70
1.75
1.80

Power
0.78
0.83
0.88
0.91
0.94

Persistent, Confirmed Islet Autoantibodies (IA) Outcome
The persistent, confirmed IA outcome is defined as the presence of IA at two
consecutive visits confirmed by two separate laboratories. TEDDY participants are
screened for glutamic acid decarboxylase autoantibodies (GAD65), insulinomaassociated antigen-2 autoantibodies (IA-2), and insulin autoantibodies (IAA) every 3
months, starting at age 3 months. Samples are initially sent to one of two TEDDY
Central Autoantibody Laboratories for testing depending on geographical residence:
Barbara Davis Center (Aurora, Colorado) or University of Bristol (Bristol, UK). If the test
result is positive for GAD65, IA-2, or IAA, the sample is sent to the second laboratory for
confirmation. Participants who receive positive results from both laboratories are
considered to have confirmed IA. The participant will also be tested at his/her next study
visit 3 months later. If both laboratories again indicate positive results, then the
participant is considered to have persistent, confirmed IA. Children who had a confirmed
antibody-positive result and were diagnosed with T1D prior to or at their next study visit
were also deemed to have persistent, confirmed IA. Only participants identified as
having persistent, confirmed IA are considered to have developed the autoimmunity
outcome for the purposes of this analysis.
Two variables related to the persistent, confirmed IA outcome were created for
this analysis. A binary variable was created to indicate whether the participant had
developed persistent, confirmed IA throughout the course of study follow-up with “1”
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indicating the participant had developed persistent, confirmed IA and “0” indicating that
the participant had not developed persistent, confirmed IA. A continuous variable was
also created to indicate the time until the participant developed persistent, confirmed IA
or was censored. For participants with the event of interest (development of persistent,
confirmed IA), this time variable represents the number of days from participant birth to
the date of the blood draw associated with the persistent, confirmed IA determination
(event date). For participants without the event of interest (no persistent, confirmed IA),
this time variable represents the number of days from participant birth to the date of the
participant’s last antibody-negative specimen sample date (censor date).

Type 1 Diabetes (T1D) Outcome
The TEDDY Study recognizes T1D diagnosis if at least one of the following
American Diabetes Association (ADA) criteria is met on two occasions (unless criterion 4
is present, in which case a single occasion is sufficient for diagnosis):
1. Casual (any time of day without regard to time since last meal) plasma
glucose ≥ 200 mg/dL, if accompanied by unequivocal symptoms (i.e. polyuria,
polydipsia, polyphagia, and/or weight loss)
2. Fasting (no food or drinks except water for at least 8 hours) plasma glucose ≥
126 mg/dL
3. 2-hour plasma glucose ≥ 200 mg/dL in oral glucose tolerance test
4. Unequivocal hyperglycemia with acute metabolic decompensation (diabetic
ketoacidosis)
These criteria are defined on the TEDDY T1D diagnosis data collection form (Appendix
2). Once a T1D diagnosis is established for a participant using this criteria, data is
collected on the diagnosis (i.e., date of diagnosis, symptoms, lab results) and further
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study follow-up is discontinued. The TEDDY definition based on ADA criteria was also
utilized for the purposes of this analysis.
Two variables related to T1D diagnosis outcome were created for this study. A
binary variable was created to indicate whether the participant had been diagnosed with
T1D with “1” indicating the participant had been diagnosed with T1D and “0” indicating
that the participant had not been diagnosed with T1D. A continuous variable was also
created to indicate the time until the participant was diagnosed with T1D or was
censored. For participants with the event of interest (T1D diagnosis), this time variable
represents the number of days from participant birth to the T1D diagnosis date (event
date). For participants without the event of interest (no T1D diagnosis), this time variable
represents the number of days from participant birth to the date of the participant’s last
visit date (censor date).

Potential Confounders
Potential confounders for the proposed analysis include: country of residence,
age, sex, maternal education, HLA type, first degree relative with T1D status, smoking
during pregnancy, drinking during pregnancy, illnesses/conditions during pregnancy,
maternal age at birth, birth weight, exclusive breastfeeding, formula exposure, cow milk
exposure, vaccination, social group exposure, and crowding (residence density).

Potential Confounder Definitions
Demographic variables including participant sex and maternal education level
were collected during infant screening for the TEDDY study. Sex was classified as either
male or female. Maternal education was collected at the 3-month study visit and
classified as primary school through some trade school, graduated from trade school or
some college/university education, or graduated from a college/university. Country
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classification was based on where the clinical center which enrolled the participant was
located (United States, Finland, Germany, or Sweden). Participant age was calculated
as the number of days from the participant’s date of birth to the participant’s last study
visit date.
T1D risk characteristics including HLA testing results and first degree relative
(FDR) status were collected during TEDDY study screening. Each participant was
assigned to a HLA category based on the high risk allele identified during screening as
outlined in Table 1. A separate variable for FDR status was coded to indicate whether or
not the participant had a mother, father, and/or sibling who had been diagnosed with
T1D, with “1” assigned to participants who have a FDR with T1D and “0” assigned to
participants who do not have a FDR with T1D.
Prenatal exposures were collected from the TEDDY child’s mother at the 3month study visit. Whether or not the mother smoked during each individual pregnancy
trimester was reported during the visit. This information was then recoded into one
variable that indicated whether or not the mother had smoked at all during pregnancy
with “1” assigned to participants whose mother had smoked at least once during
pregnancy and “0” assigned to participants whose mother had not smoked at all during
pregnancy. Drinking during pregnancy was coded into one variable for the analysis
structured in the same manner as described for the smoking during pregnancy variable.
Illnesses and conditions during pregnancy were reported by the mother at the 3-month
visit as well. A binary variable was created from these data to indicate whether the
participant’s mother reported at least one illness or condition during pregnancy, assigned
as “1”, or whether the mother did not report any illnesses or conditions during
pregnancy, assigned as “0”. Maternal age at birth was calculated from the mother’s date
of birth and participant’s date of birth and utilized as a continuous variable. Birth weight
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was collected during the 3-month study visit in pounds and ounces. The measurement
was converted to grams and utilized as a continuous variable.
Breastfeeding, formula, and cow milk exposures were collected every 3 months
beginning at the 3-month study visit. Exclusive breastfeeding data on exposure and
duration were recoded into one variable to summarize the length of time each participant
was exposed to exclusive breastfeeding with the following categories: no exclusive
breastfeeding (includes participants who breastfed once in the hospital only), <3 months
of exclusive breastfeeding, and ≥3 months of exclusive breastfeeding. Exclusive
breastfeeding duration is defined as the period of time for which breast milk was the only
source of nutrition for the TEDDY child with no other food or formula introduced during
this period. Data indicating whether or not the participant had been introduced to any
infant formula and the age at introduction was combined into one summary variable with
the following categories: not introduced in the first 9 months of life, introduced at age <3
months, introduced between age 3 months to <7.5 months, and introduced at age 7.5
months to <9 months. Data on cow milk exposure, consumed as a drink or mixed into
another food product, was summarized in the same manner as described for formula.
Vaccination history was also collected every 3 months beginning at the 3-month
visit. This data was compiled into one binary variable indicating whether or not the
participant had ever received any type of vaccination. Participants for whom at least one
vaccination was received in the first 9 months of life were coded as “1” and participants
for whom no vaccinations were received in the first 9 months of life were coded as “0”.
At the 9-month study visit, the primary caretaker was asked to report the number
of children under the age of 18 years living in the TEDDY child’s household, the number
of adults age 18 years and older living in the TEDDY child’s household, and the number
of rooms in the TEDDY child’s home not including bathrooms, porches, halls, or
balconies. A household crowding score representing residence density was calculated
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for each participant from this information by dividing the total number of people in the
household, adults plus children, by the number of rooms in the house. Additionally, at
the same visit the primary caretaker was asked to identify which of the following
residence types best describes where the TEDDY child lives: rural area, small
city/village, suburb, or big city.
Social group exposure data was collected from the TEDDY child’s primary
caretaker every 3 months beginning at the 3-month study visit. Social group exposure
was defined as regular (once a week or more) day care or other social gathering that
included at least one other child, who is not a sibling, in addition to the TEDDY child. A
binary variable was created to indicate whether the TEDDY child had been exposed to a
social group in the first 9 months of life. Children for whom an early life (in the first 9
months) social group experience had been reported were coded as “1” and children for
whom an early life social group experience had not been reported were coded as “0”.

Data Preparation for Statistical Analysis
The dataset was reviewed for data entry errors to prepare the dataset for
analysis. Crowding space (residence density) values were coded as missing if any of the
variables included in the calculation (number of children, number of adults, or number of
rooms in home) were reported as an inappropriate value (e.g., -3 rooms, -2 adults).
Crowding space was coded as missing for a total of nine participants due to
inappropriate values. No other data entry errors were identified.
Skewness was calculated for each variable. The skewness measure indicates
the degree and direction of asymmetry of the data distribution for a given variable.
Crowding space was the only continuous variable with a skewness value greater than
three standard deviations. To normalize the skewed distribution, participants were
categorized as having a crowding score of less than or equal to 1 or greater than 1.
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Missingness was assessed for each variable by reviewing the frequencies of
values for each variable. All variables were missing less than 3% of values. Missing
trends were further assessed by tabulating the number of missing variables of interest
for each participant in order to determine if a few participants were missing the majority
of the variables and to consider whether participants should be removed from the
analysis due to a high number of missing variables. A total of 174 participants were
missing one variable only, 65 participants were missing two variables, and two
participants were missing three variables. Since participants were only missing three
variables at most and very few participants were missing more than two variables, no
participants were removed due to frequency of missing variables.

Statistical Analysis
Analysis Overview
The association between early life animal exposure and persistent, confirmed IA
and the association between early life animal exposure and T1D were explored using
Cox proportional hazards (PH) models. A propensity score analysis was applied to
control for confounding when assessing the relationship between the exposure and
outcomes of interest. Propensity scores, calculated by logistic regression, represent the
probability of a participant being exposed to animals based on the other data collected
on that participant. The propensity score analysis was applied in three different ways: by
adjustment for the propensity score variable in the Cox proportional hazards model, by
stratification on propensity score groups, and by propensity score pair matching. Details
on the methods addressed in this brief overview follow.
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Univariate Analysis
Frequencies were tabulated for each variable in order to assess missingness and
distribution by exposure status. Chi-square tests were performed on each categorical
variable to determine whether the proportions for each variable were equal for the
exposed and unexposed study groups. Chi-square test p-values of less than 0.05
indicate a statistically significant difference in proportions by exposure status. T-tests
were utilized to determine if the means of continuous variables were equal across the
exposed and unexposed groups. T-test p-values of less than 0.05 indicate a statistically
significant difference in the means of the tested variable by exposure status. Degree of
correlation between variables and early life animal exposure status was also explored for
the purpose of assessing multicollinearity.
The association between early life animal exposure and each outcome of interest
was first examined by Kaplan-Meier survival curves to determine if there was any
difference in outcome risk by exposure status. The log rank test was performed to
provide a quantitative value indicating whether there was a statistically significant
difference in risk by exposure status. Log rank test p-values of less than 0.05 indicate a
statistically significant difference between assessed survival curves.

Logistic Regression for the Calculation of Propensity Scores
Propensity scores allow for the investigation of the association between early life
animal exposure and risk of IA and T1D by simulating a randomized controlled trial from
the dataset. The propensity score is the probability of a participant receiving “treatment”
based on that participant’s characteristics. In this case, the treatment of interest is early
life animal exposure.
An early life animal exposure propensity score was calculated for each study
participant by stepwise logistic regression. The propensity score calculated for each
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participant represents the predicted probability of early life animal exposure for that
participant based on other characteristics of the participant. Early life animal exposure is
considered the outcome and other covariates (e.g., sex, country of residence) are
considered predictors when calculating the propensity scores. Logistic regression is
appropriate for the analysis due to the binary structure of the outcome variable, early life
animal exposure (1=animal exposure in first 9 months of life, 0=no animal exposure in
first 9 months of life). Stepwise logistic regression was utilized so that all potential
variables that may affect the probability of a participant having early life animal exposure
can be considered and variables that do not affect the probability of a participant having
early life animal exposure could be excluded with the overall goal being to determine the
most effective set of variables for predicting the outcome.
Environmental and demographic characteristics that may affect the probability of
one having early life exposure to animals were of interest for the logistic regression
model. All covariates were included in the initial stepwise logistic regression model, with
the exception of HLA and participant age at last visit. HLA is an indicator of genetic risk
for T1D and was included in the survival analysis. Age at last visit is represented by the
time to event (outcome or censoring) in the survival analysis. The regression model was
set to require a significance level of 0.1 for entry into the model and a significance level
of 0.1 to stay in the model. Propensity scores predicting early life animal exposure were
calculated utilizing the final logistic regression model.
The propensity score calculated for each participant was added to the dataset as
a single continuous variable. Additionally, each study participant was assigned a quintile
based on propensity score, ranging from quintile 1 with the lowest propensity scores
(least likely to have early life animal exposure) to quintile 5 with the highest propensity
scores (most likely to have early life animal exposure). Interactions between early life
animal exposure and predictors in the final logistic regression model were assessed by
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calculating the measure of association for early life animal exposure and each outcome
of interest by predictor variable category. For example, for the early life vaccination
variable the measure of association between early life animal exposure and IA was
calculated among participants who received early life vaccinations and then separately
among participants who did not receive early life vaccinations for comparison.

Cox Proportional Hazards Analysis
The risk of persistent, confirmed IA and T1D by early life animal exposure status
was examined by Cox proportional hazards modeling. Cox proportional hazards
modeling is a type of survival analysis. In a conventional sense, survival would be
interpreted as the probability of death and time until death. In health outcomes research,
survival can be applied to the probability of a health outcome (e.g., T1D diagnosis) and
the time until the health outcome (e.g., the time from birth to diagnosis of T1D). In other
words, we can use survival analysis techniques to calculate the instantaneous risk for an
outcome. Advantages of using survival analysis methods include the ability to account
for the differing periods of time each participant contributes to the study and the ability to
analyze the effect of predictors on time to outcome in addition to whether or not the
outcome occurred. The Cox proportional hazards model is considered a semiparametric
method, because the distribution of the underlying hazard does not need to be known or
assumed.
The primary assumptions of the Cox proportional hazards model are that the
hazards are proportional and independent of time and that censoring is independent of
event occurrence. The proportionality assumption was tested by randomly simulating
1000 empirical score processes, based on martingale residuals, that meet the
proportional hazards assumption for the variable early life animal exposure in regard to
each outcome of interest and then calculating a p-value representing the percent of
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simulated paths which had extreme points exceeding the most extreme point on the
observed path for the variable of interest. A resulting p-value less than 0.05 would
indicate evidence against the proportional hazards assumption.
The binary early life animal exposure variable indicating actual animal exposure
status was included in each Cox proportional hazards model as the independent
variable. The risk of T1D and persistent, confirmed IA for the exposed group compared
to the unexposed group (which serves as the reference group) is reported as a hazard
ratio (HR) and corresponding 95% confidence interval (CI) for each model. HRs equal to
1 indicate that there is no difference in risk between the exposed and unexposed groups.
The 95% CIs that include 1 indicate that the calculated HR is not statistically significant.
An unadjusted Cox proportional hazards model was run on the entire study
population for each outcome, including only early life animal exposure as the
independent variable and the outcome (T1D or IA) as the dependent variable, to
determine the risk of the outcomes by exposure status prior to adjusting for any
confounders. The risks of T1D and IA by early life animal exposure were then further
assessed by incorporating the propensity scores into the Cox proportional hazards
models in three ways, as described in detail in the three following sections.

Propensity Score Application 1: Adjusting for Propensity Score within the Cox
Proportional Hazards Model
In order to measure the risk of persistent, confirmed IA by early life animal
exposure status while controlling for confounding, a Cox proportional hazards model was
created that included the binary early life animal exposure variable and the continuous
propensity score variable as independent variables and the binary IA outcome variable
as the dependent variable. The model was run on the entire study dataset and the
resulting HR and 95% CI were reported. The same procedure was repeated for the T1D
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outcome. A second adjusted model that included early life animal exposure, propensity
score, and HLA was also created for each outcome and then run on the entire study
dataset in order to control for HLA as a potential confounder in addition to propensity
score. DQ8/8 was defined as the reference group for HLA. The HR indicating the risk of
the exposed group compared to the unexposed group (the reference group) was
reported along with the 95% CI for each model.

Propensity Score Application 2: Stratification on Propensity Score Quintiles
The effect of early life animal exposure on the risk of each endpoint (T1D and
persistent, confirmed IA) was examined within propensity score quintiles in order to
further explore the relationship between early life animal exposure and the endpoints of
interest. This method provided the opportunity to examine the effect of early life animal
exposure on T1D and IA risk in groups of participants with similar propensity for early life
animal exposure. This allows one to control for differences within the study population by
studying the association in homogenous groups of people (participants with similar
propensity scores and therefore similarities in the characteristics included in the final
logistic regression model used to calculate the propensity score).
Two Cox proportional hazards models were run in each propensity score quintile
to determine the risk of the outcome (persistent, confirmed IA or T1D diagnosis) among
those actually exposed to animals within specified quintile compared to those not
actually exposed to animals within specified quintile:
1. An unadjusted Cox proportional hazards model for each outcome that
included only early life animal exposure in the model.
2. An adjusted Cox proportional hazards model for each outcome that included
both early life animal exposure and HLA in the model. DQ8/8 was defined as
the reference group for HLA.
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Two sets of these models were created, one for the outcome T1D and one for the
outcome persistent, confirmed IA. Therefore, a total of four different Cox proportional
hazards models were run in each quintile. For each endpoint, Kaplan-Meier survival
curves were plotted by propensity quintile and homogeneity of risk across propensity
quintiles was assessed by log rank test.

Propensity Score Application 3: Propensity Score Pair Matching
Exposed and unexposed participants were pair-matched by propensity score in
order to ensure that compared participants were as similar as possible in an effort to
thoroughly tease out any potential association between early life animal exposure and
the endpoints IA and T1D. Participants were matched using the greedy match macro
available from Mayo Clinic (23) as described by Faries et al. (24). A difference in
propensity score of up to 0.1 was permitted. Two Cox proportional hazards models were
run, stratified by matched pair, to determine the risk of the outcome (persistent,
confirmed IA or T1D diagnosis) among those actually exposed to animals in early life
compared to those not actually exposed to animals in early life:
1. An unadjusted Cox proportional hazards model for each outcome that
included only early life animal exposure in the model, stratified by matched
pair.
2. An adjusted Cox proportional hazards model for each outcome that included
both early life animal exposure and HLA in the model, stratified by matched
pair. DQ8/8 was defined as the reference group for HLA.
Two sets of these models were created, one for the outcome T1D and one for the
outcome persistent, confirmed IA. Therefore, a total of four different Cox proportional
hazards models were run on the matched dataset.
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Results
Descriptive Statistics
A total of 7,432 TEDDY participants met the study eligibility criteria and were
included in the final study population. Of this study population, 3,987 (54%) participants
had been exposed to animals prior to 9 months of age and 3,445 (46%) participants had
not been exposed to animals prior to 9 months of age. The study population overall, as
well as broken down by exposure status, is described in Table 4.
The proportions of sex, FDR, pregnancy conditions, maternal age, early life
formula introduction, and early life vaccination categories were consistent between the
exposed and unexposed study populations (p≥0.05); however, there were significant
differences across exposure groups for other variables. Compared to the unexposed
population, the exposed population included fewer mothers who had graduated college
(p<0.0001), more mothers who had smoked during pregnancy (p=0.0005), more
mothers who drank alcohol during pregnancy (p=0.003), more participants without an
exclusive breastfeeding experience (p=0.0002), and more participants who were
introduced to cow milk prior to 3 months of age (p=0.0003). Additionally, participants in
the exposed group had a lower mean birth weight (p=0.008) and were slightly younger
as of the last study visit (p=0.04) than participants in the unexposed group.
Characteristics of the environment in which the participants lived, both in terms of
crowding (residence density) and residence type, differed significantly between the
exposed and unexposed groups (p=0.0003 and p<0.0001, respectively). The exposed
group had a much higher percentage of participants who lived in a rural environment

26

(20%) than the unexposed group (8%). The exposed group also had fewer participants
in a crowded environment (9%) than the unexposed group (11%).
Additionally, country distribution was vastly different between the exposed and
unexposed populations (p<0.0001). The most striking difference is the distribution of
U.S. participants. The exposed group included 2,091 (52%) U.S. participants; whereas,
the unexposed group included only 966 (28%) U.S. participants. Furthermore, the
exposed group included fewer participants from Finland (15%), Germany (6%), and
Sweden (27%) than the unexposed group which included 30%, 7%, and 35%,
respectively. Distribution of HLA allele type also varied greatly between the exposed and
unexposed populations (p<0.0001). Notably, there were more DQ8/4 allele types in the
unexposed population (19%) than in the exposed population (15%), which is likely linked
to higher prevalence of Finnish participants in the unexposed population, since the HLA
DQ8/4 genotype is more prevalent in this TEDDY country-specific population (25).
A total of 417 (6%) participants in the study population developed persistent,
confirmed IA. Of these participants, 221 (53%) were exposed to animals early in life
(prior to 9 months of age) and 196 (47%) were not exposed to animals early in life (Table
5). The Kaplan-Meier survival curves detailing cumulative incidence of IA by early life
animal exposure are shown in Figure 2. There is not a statistically significant difference
between the survival curves for IA by early life animal exposure (p=0.92).
A total of 113 (2%) participants in the study population were diagnosed with T1D.
Of these participants, 59 (52%) were exposed to animals early in life and 54 (48%) were
not exposed to animals early in life (Table 6). The Kaplan-Meier survival curves detailing
cumulative incidence of T1D by early life animal exposure are shown in Figure 3. There
is not a statistically significant difference between the survival curves for T1D by early
life animal exposure (p=0.89).

27

Table 4: Descriptive Statistics of the Study Population for the Analysis of Early Life
Animal Exposures and Risk of IA and T1D
Variable

Sex
Female
Male
Age at Last Visit, years
(mean, SD)
HLA Allele
DQ2/2
DQ8/2
DQ8/8
DQ8/4
Other
First Degree Relative with
T1D
Yes
No
Country of Residence
United States
Finland
Germany
Sweden
Residence Type
Rural Area
Small City/Village
Suburb
Big City
Missing
Crowding Space
(Residence Density)
>1 (Crowded)
≤ 1 (Not Crowded)
Missing
Mother’s Education Level
Basic Primary Education
Graduated Trade School
Graduated College
Missing
Mother Smoked During
Pregnancy
Yes
No
Missing
Mother Drank Alcohol
During Pregnancy
Yes
No
Missing

All
N=7432
N (%)

Exposed to
Animals in
Early Life
N=3987
N (%)

Not Exposed
to Animals in
Early Life
N=3445
N (%)

P-value

3646 (49.06)
3786 (50.94)

1970 (49.41)
2017 (50.59)

1676 (48.65)
1769 (51.35)

0.5132

4.23 (1.83)

4.19 (1.81)

4.28 (1.86)

0.0422

1541 (20.73)
2894 (38.94)
1476 (19.86)
1283 (17.26)
238 (3.2)

844 (21.17)
1631 (40.91)
766 (19.21)
613 (15.37)
133 (3.34)

697 (20.23)
1263 (36.66)
710 (20.61)
670 (19.45)
105 (3.05)

<0.0001

816 (10.98)
6616 (89.02)

449 (11.26)
3538 (88.74)

367 (10.65)
3078 (89.35)

0.4028

3057 (41.13)
1617 (21.76)
497 (6.69)
2261 (30.42)

2091 (52.45)
584 (14.65)
252 (6.32)
1060 (26.59)

966 (28.04)
1033 (29.99)
245 (7.11)
1201 (34.86)

<0.0001

1064 (14.35)
2378 (32.06)
2859 (38.55)
1116 (15.05)
15

785 (19.74)
1127 (28.34)
1566 (39.38)
499 (12.55)

279 (8.11)
1251 (36.37)
1293 (37.59)
617 (17.94)

<0.0001

727 (9.85)
6654 (90.15)
51

344 (8.68)
3617 (91.32)

383 (11.20)
3037 (88.80)

0.0003

1299 (17.74)
1853 (25.31)
4170 (56.95)
110

737 (18.77)
1070 (27.25)
2120 (53.99)

562 (16.55)
783 (23.06)
2050 (60.38)

<0.0001

895 (12.15)
6469 (87.85)
68

529 (13.38)
3424 (86.62)

366 (10.73)
3045 (89.27)

0.0005

2546 (34.56)
4820 (65.44)
66

1426 (36.08)
2526 (63.92)

1120 (32.81)
2294 (67.19)

0.0032
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Mother Experienced a
Condition or Illness During
Pregnancy
Yes
No
Mother’s Age at Birth of
Participant, years
mean (SD)
Participant Birth Weight,
grams
mean (SD)
Missing
Exclusive Breastfeeding
Duration
No exclusive breastfeeding
<3 months
≥ 3 months
Early Life Formula
Introduction Age
Not introduced
Introduced at <3 months
Introduced at 3-<7.5 months
Introduced at 7.5-<9 months
Missing
Early Life Cow Milk
Introduction Age
Not introduced
Introduced <3 months
Introduced 3-<7.5 months
Introduced 7.5-<9 months
Missing
Early Life Vaccination
Yes
No
Early Life Social Group
Yes
No

6767 (91.05)
665 (8.95)

3634 (91.15)
353 (8.85)

3133 (90.94)
312 (9.06)

0.7600

31.13 (5.16)

31.09 (5.28)

31.18 (5.03)

0.4768

3503.6 (543.80)
189

3487.7 (543.4)

3521.8 (543.7)

0.0077

2764 (37.19)
2838 (38.19)
1830 (24.62)

1551 (38.90)
1523 (38.20)
913 (22.90)

1213 (35.21)
1315 (38.17)
917 (26.62)

0.0002

1094 (15.11)
5196 (71.78)
827 (11.42)
122 (1.69)
193

554 (14.36)
2821 (73.12)
419 (10.86)
64 (1.66)

540 (15.97)
2375 (70.25)
408 (12.07)
58 (1.72)

0.0574

25 (0.36)
5058 (73.01)
1618 (23.35)
227 (3.28)
504

13 (0.35)
2769 (75.14)
786 (21.33)
117 (3.18)

12 (0.37)
2289 (70.58)
832 (25.66)
110 (3.39)

0.0003

7077 (95.22)
355 (4.78)

3783 (94.88)
204 (5.12)

3294 (95.62)
151 (4.38)

0.1393

4800 (64.59)
2632 (35.41)

2624 (65.81)
1363 (34.19)

2176 (63.16)
1269 (36.84)

0.0172

Table 5: Cross-tabulation of Early Life Animal Exposure and Persistent, Confirmed IA
Early Life Animal
Exposure
No Early Life Animal
Exposure
Total

IA
N (%)

No IA
N (%)

Total
N (%)

221 (52.99)

3766 (53.68)

3987 (53.65)

196 (47.00)

3249 (46.32)

3445 (46.35)

417 (5.61)

7015 (94.39)

7432 (100)
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Figure 2: Kaplan-Meier Survival Curve, Cumulative Incidence of Persistent, Confirmed
IA by Early Life Animal Exposure, Log Rank P=0.92

Figure 3: Kaplan-Meier Survival Curve, Cumulative Incidence of T1D by Early Life
Animal Exposure, Log Rank P=0.89
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Table 6: Cross-tabulation of Early Life Exposure to Animals and T1D
Early Life Animal
Exposure
No Early Life Animal
Exposure
Total

T1D
N (%)

No T1D
N (%)

Total
N (%)

59 (52.21)

3928 (53.67)

3987 (53.65)

54 (47.79)

3391 (46.33)

3445 (46.35)

113 (1.52)

7319 (98.48)

7432 (100)

Logistic Regression
All variables of interest (listed in Table 4) that were thought to potentially impact
the probability that one would be exposed to an animal/pet were included in the initial
logistic regression model and then assessed by stepwise logistic regression. This
resulted in all variables of interest being included in the initial model with the exception of
HLA allele type and participant age at last visit, which would be accounted for in the
survival analysis instead. Stepwise logistic regression, based on a significance level of
0.1 for entry and to stay in the model, resulted in a final model including eight variables:
country of residence, residence type, smoking by the mother during pregnancy,
crowding space (residence density), early life vaccination, maternal education, early life
social group exposure, and drinking alcohol by the mother during pregnancy.
The final logistic regression model was used to create the propensity score for
each participant, representing the probability of early life animal exposure based on the
eight variables included in the final model (country of residence, residence type, smoking
by the mother during pregnancy, crowding space, early life vaccination, maternal
education, early life social group exposure, and drinking alcohol by the mother during
pregnancy) as predictors. Only those participants with complete data (N=6,532) for the
variables assessed in the stepwise logistic regression were included in the logistic
regression analysis. The odds ratios (OR) and corresponding 95% confidence intervals
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(CI) as well as the p-values associated with each of the variables included in the final
model are listed in Table 7.

Table 7: Final Logistic Regression Model for Early Life Animal Exposure Propensity
Score Calculation, Stepwise Logistic Regression, Significance Level of 0.1 for Model
Entry and to Stay in Model, N=6,532
Variable
Country of Residence (Ref = United States)
Finland
Germany
Sweden
Residence Type (Ref = Big City)
Rural
Small city/village
Suburb
Smoking During Pregnancy (Ref= None)
Crowding Space (Ref = Crowding Score ≤1)
Early Life Vaccination (Ref = None)
Maternal Education (Ref = Primary Education)
Graduated Trade School/Some College
Graduated College
Early Life Social Group Exposure (Ref = None)
Drinking During Pregnancy (Ref = None)

OR (95% CI)

P-value

0.20 (0.17-0.23)
0.39 (0.31-0.48)
0.31 (0.27-0.36)

<0.0001

5.87 (4.75-7.25)
1.81 (1.52-2.14)
1.50 (1.28-1.76)
1.35 (1.14-1.59)
0.74 (0.61-0.89)
1.50 (1.15-1.94)

<0.0001

0.96 (0.81-1.13)
0.78 (0.67-0.91)
1.17 (1.04-1.31)
1.11 (0.99-1.25)

<0.0001
0.0010
0.0036
0.0027
0.0045
0.0601

These results indicate that the odds of being exposed to animals early in life
among participants in Finland, Germany, or Sweden are lower than the odds of being
exposed to animals early in life among participants in the U.S. The odds of being
exposed to animals early in life among those living in a rural environment are 5.9 times
(OR: 5.87, 95% CI: 4.75-7.25) the odds of being exposed to animals early in life among
those living in a big city. Also in regard to environment, those who live in a crowded
environment have lower odds (OR: 0.74, 95% CI: 0.61-0.89) of early life animal
exposure than those who do not live in a crowded environment. Those participants
whose mothers smoked during pregnancy have higher odds (OR: 1.35, 95% CI: 1.141.59) of early life animal exposure than those whose mothers did not and those whose
mothers drank alcohol during pregnancy have higher odds (OR: 1.11, 95% CI: 0.991.25) of early life animal exposure than those whose mothers did not. Additionally, those
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who received early life vaccinations have higher odds (OR: 1.50, 95% CI: 1.15-1.94) of
early life animal exposure than those who did not and those who had early life social
group experiences have higher odds (OR: 1.17, 95% CI: 1.04-1.31) of early life animal
exposure than those who did not.

Propensity Score Application 1
The association between early life animal exposure and each outcome was first
explored by examining the study population (N=7,432) as a whole. Propensity scores
could not be calculated for 241 participants who were missing at least one of the eight
variables included in the final logistic regression model used to calculate the propensity
scores. The Cox proportional hazards models utilized to assess the association between
early life animal exposure and each outcome were run on the 7,191 participants for
whom propensity scores could be calculated.

Outcome: Persistent, Confirmed IA
Before controlling for any other variables, the hazard ratio (HR) for the risk of
persistent, confirmed IA among those with early life animal exposure compared to those
without early life animal exposure was 1.02 with a 95% CI of 0.84-1.24. Since the 95%
CI for this basic unadjusted association includes 1, the finding is not statistically
significant. Therefore, no difference in risk of persistent, confirmed IA was found
between those participants with early life animal exposure and those without early life
animal exposure.
The propensity score variable was added to the original unadjusted model in
order to control for the variables that were predictive of early life animal exposure and
determine if the HR was altered by the adjusted model (Table 8, Adjusted Model 1).
When adjusted for early life animal exposure propensity, the resulting HR was 1.11
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(0.90-1.37). This measure of association indicates that there is no significant difference
in IA risk between those with early life animal exposure and those without early life
animal exposure.
Adjusting for HLA type in addition to propensity score (Table 8, Adjusted Model
2) had little additional impact on the HR (HR 1.09, 95% CI: 0.89-1.35). This finding was
not statistically significant and indicates no significant difference in risk between the
exposed and unexposed. Ultimately, no statistically significant associations were
identified between early life animal exposure and persistent, confirmed IA by the models
run on the entire study population. The findings of these models are summarized in
Table 8.

Table 8: HR & 95% CI for Early Life Animal Exposure and Persistent, Confirmed IA by
Cox PH Models Fit to the Entire Study Population
Risk of IA for Participants with Early Life Animal Exposure1
Variable

Unadjusted Model
N=7191
HR (95% CI)

Adjusted Model 1
N=7191
HR (95% CI)

Adjusted Model 2
N=7191
HR (95% CI)

Early Life
Animal
1.02 (0.84-1.24)
1.11 (0.90-1.37)
1.09 (0.89-1.35)
Exposure
1
The unadjusted model includes early life animal exposure only (reference group unexposed).
Adjusted model 1 is adjusted for early life animal exposure propensity score. Adjusted model 2 is
adjusted for propensity score and HLA (reference group DQ8/8).

Outcome: T1D
Before controlling for any other variables, the HR for the risk of T1D among those
with early life animal exposure compared to those without early life animal exposure was
0.98 with a 95% CI of 0.67-1.42. Since the 95% CI for this basic unadjusted association
includes 1, the finding is not statistically significant and indicates no difference in risk
between the exposed and unexposed groups. As was done for analysis of IA risk,
propensity score was added to the analysis for T1D risk in order to control for the
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variables that were predictive of early life animal exposure and determine if the HR was
altered by the adjusted model. When adjusted for early life animal exposure propensity
(Table 9, Adjusted Model 1), the resulting HR for T1D risk was 1.04 (0.69-1.54). This
measure of association indicates that there is no significant difference in T1D risk
between those with early life animal exposure and those without early life animal
exposure.
Adjusting for HLA type in addition to propensity score (Table 9, Adjusted Model
2) also resulted in no significant difference in the risk of T1D between the exposed and
unexposed groups (HR: 1.01, 95% CI: 0.67-1.50). In summary, none of the measured
associations between early life animal exposure and T1D, examined by running models
on the entire study population, indicated a statistically significant difference in risk
between the exposed and unexposed. The findings of these models are summarized in
Table 9.

Table 9: HR & 95% CI for Early Life Animal Exposure and T1D by Cox PH Models Fit to
the Entire Study Population
Risk of T1D for Participants with Early Life Animal Exposure1
Variable

Unadjusted Model
N=7191
HR (95% CI)

Adjusted Model 1
N=7191
HR (95% CI)

Adjusted Model 2
N=7191
HR (95% CI)

Early Life
Animal
0.98 (0.67-1.42)
1.04 (0.69-1.54)
1.01 (0.67-1.50)
Exposure
1
The unadjusted model includes early life animal exposure only (reference group unexposed).
Adjusted model 1 is adjusted for early life animal exposure propensity score. Adjusted model 2 is
adjusted for propensity score and HLA (reference group DQ8/8).

Propensity Score Application 2
Quintiles Overview
The total number of participants in each propensity score quintile ranges from
1396 to 1481 with each quintile representing 19% to 20% of the total study population.
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The propensity score range of each quintile, as well as the distribution of exposure and
outcomes across quintiles, is detailed in Table 10. Quintile 1 includes those participants
with the lowest propensity scores indicating that they have a low probability of early life
animal exposure. Conversely, quintile 5 includes those participants with the highest
propensity scores indicating that these participants have a high probability of early life
animal exposure. As expected, quintile 1 (the quintile with the lowest propensity scores)
had the lowest percent of exposed participants. The percent exposed then increased
with each quintile through quintile 5 (the quintile with the highest propensity scores)
which had the highest percent of exposed participants. This indicates that the propensity
scores were appropriately predicting early life animal exposure in the study population.
Propensity scores could not be calculated for 241 participants who were missing at least
one of the eight variables included in the final logistic regression model used to calculate
the propensity scores. As shown in Table 10, the group of participants for whom
propensity score could not be calculated had a high proportion of early life animal
exposure (54%) and a low proportion of IA (4%) and T1D (<1%) which may attenuate
the HRs calculated for these outcomes. The characteristics of study participants by
propensity score quintile are further detailed in Table 11.
The Kaplan-Meier survival curves for persistent, confirmed IA by early life animal
exposure propensity quintile are shown in Figure 4 and the Kaplan-Meier curves for T1D
by early life animal exposure propensity quintile are shown in Figure 5. There is not a
statistically significant difference between the survival curves for IA by early life animal
exposure propensity quintile (p=0.57) or between the survival curves for T1D by early life
animal exposure propensity quintile (p=0.76).
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Table 10: Early Life Animal Exposure Propensity Score Quintiles: Range, Total, Number
Exposed, Number with Persistent Confirmed IA, and Number with T1D
Propensity
Score Quintile

Propensity Score
Range

Total
N (%)

Exposed
N (%)

1
2
3
4
5
Missing

0.140-<0.355
0.355-<0.470
0.470-<0.619
0.619-<0.689
0.689-<0.938

1444 (19.43)
1431 (19.25)
1439 (19.36)
1481 (19.93)
1396 (18.78)
241 (3.24)

409 (28.32)
554 (38.71)
857 (59.56)
1017 (68.67)
1019 (72.99)
131 (54.36)

IA
Outcome
N (%)
99 (6.86)
83 (5.80)
80 (5.56)
77 (5.20)
68 (4.87)
10 (4.15)

T1D
Outcome
N (%)
29 (2.01)
23 (1.61)
22 (1.53)
22 (1.49)
15 (1.07)
2 (0.83)
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Figure 4: Survival Curves for Persistent, Confirmed IA by Early Life Animal Exposure
Propensity Score Quintile (Survival by Time to Event), Log Rank P=0.57
Kaplan-Meier Survival Curve for T1D by Early Life Animal Exposure Quintile
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Figure 5: Survival Curve for T1D by Early Life Animal Exposure Propensity Score
Quintile (Survival by Time to Event), Log Rank P=0.76
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Table 11: Descriptive Statistics of the Study Population by Early Life Animal Exposure Propensity Quintile
Variable

Early Life Animal Exposure
Yes
No
Sex
Female
Male
Age at Last Visit, years
(mean, SD)
HLA Allele
2/2
8/2
8/8
8/4
Other
First Degree Relative with T1D
Yes
No
Country of Residence
United States
Finland
Germany
Sweden
Residence Type
Rural Area
Small City/Village
Suburb
Big City
Crowding Space (Residence Density)
>1 (Crowded)
≤ 1 (Not Crowded)

Early Life Animal Exposure Propensity Quintiles
(Lowest Propensity, Q1, to Highest Propensity, Q5, for Animal Exposure)
Quintile 1
N=1444
N (%)

Quintile 2
N=1431
N (%)

Quintile 3
N=1439
N (%)

Quintile 4
N=1481
N (%)

Quintile 5
N=1396
N (%)

409 (23.32)
1035 (71.68)

554 (38.71)
877 (61.29)

857 (59.56)
582 (40.44)

1017 (68.67)
464 (31.33)

1019 (72.99)
377 (27.01)

723 (50.07)
721 (49.93)

692 (48.36)
739 (51.64)

708 (49.20)
731 (50.80)

727 (49.09)
754 (50.91)

671 (48.07)
725 (51.93)

4.50 (1.84)

4.45 (1.93)

4.14 (1.87)

4.12 (1.69)

3.95 (1.75)

224 (15.51)
510 (35.32)
260 (18.01)
399 (27.63)
51 (3.53)

302 (21.10)
564 (39.41)
307 (21.45)
221 (15.44)
37 (2.59)

317 (22.03)
543 (37.73)
305 (21.2)
210 (14.59)
64 (4.45)

330 (22.28)
620 (41.86)
275 (18.57)
218 (14.72)
38 (2.57)

319 (22.85)
565 (40.47)
284 (20.34)
185 (13.25)
43 (3.08)

134 (9.28)
1310 (90.72)

136 (9.50)
1295 (90.50)

179 (12.44)
1260 (87.56)

174 (11.75)
1307 (88.25)

170 (12.18)
1226 (87.82)

0 (0)
1055 (73.06)
73 (5.06)
316 (21.88)

10 (0.70)
192 (13.42)
155 (10.83)
1074 (75.05)

586 (40.72)
193 (13.41)
181 (12.58)
479 (33.29)

1333 (90.01)
85 (5.74)
19 (1.28)
44 (2.97)

1007 (72.13)
27 (1.93)
67 (4.80)
295 (21.13)

0 (0)
489 (33.86)
525 (36.36)
430 (29.78)

4 (0.28)
808 (56.46)
513 (35.85)
106 (7.41)

194 (13.48)
597 (41.49)
191 (13.27)
457 (31.76)

133 (8.98)
102 (6.89)
1172 (79.14)
74 (5.00)

702 (50.29)
316 (22.64)
369 (26.43)
9 (0.64)

243 (16.83)
1201 (83.17)

112 (7.83)
1319 (92.17)

148 (10.28)
1291 (89.72)

100 (6.75)
1381 (93.25)

91 (6.52)
1305 (93.48)
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Mother’s Education Level
Basic Primary Education
Graduated Trade School
Graduated College
Mother Smoked During Pregnancy
Yes
No
Mother Drank Alcohol During Pregnancy
Yes
No
Mother Experienced a Condition or Illness
During Pregnancy
Yes
No
Mother’s Age at Birth of Participant, years
mean (SD)
Participant Birth Weight, grams
mean (SD)
Exclusive Breastfeeding Duration
No exclusive breastfeeding
<3 months
≥ 3 months
Early Life Formula Introduction Age
Not introduced
Introduced at <3 months
Introduced at 3-<7.5 months
Introduced at 7.5-<9 months
Early Life Cow Milk Introduction Age
Not introduced
Introduced <3 months
Introduced 3-<7.5 months
Introduced 7.5-<9 months
Early Life Vaccination
Yes
No
Early Life Social Group
Yes
No

91 (6.30)
239 (16.55)
1114 (77.15)

286 (19.99)
328 (22.92)
817 (57.09)

413 (28.70)
382 (26.55)
644 (44.75)

108 (7.29)
253 (17.08)
1120 (75.62)

365 (26.15)
611 (43.77)
420 (30.09)

73 (5.06)
1371 (94.94)

187 (13.07)
1244 (86.93)

213 (14.80)
1226 (85.20)

75 (5.06)
1406 (94.94)

310 (22.21)
1086 (77.79)

438 (30.33)
1006 (69.97)

440 (30.75)
991 (69.25)

529 (36.76)
910 (63.24)

543 (36.66)
938 (63.34)

530 (37.97)
866 (62.03)

1324 (91.69)
120 (8.31)

1322 (92.38)
109 (7.62)

1304 (90.62)
135 (9.38)

1357 (91.63)
124 (8.37)

1297 (92.91)
99 (7.09)

31.24 (4.67)

31.35 (4.82)

31.36 (5.15)

31.78 (5.14)

30.01 (5.70)

3554.25 (541.01)

3550.55 (532.34)

3510.41 (547.57)

3422.53 (524.29)

3472.89 (556.80)

442 (30.61)
571 (39.54)
431 (29.85)

425 (29.70)
573 (40.04)
433 (30.26)

501 (34.82)
588 (40.86)
350 (24.32)

723 (48.82)
449 (30.32)
309 (20.86)

589 (42.19)
540 (38.68)
267 (19.13)

232 (16.08)
970 (67.22)
204 (14.14)
37 (2.56)

271 (19.02)
974 (68.35)
165 (11.58)
15 (1.05)

201 (14.36)
997 (71.21)
177 (12.64)
25 (1.79)

187 (13.24)
1069 (75.71)
128 (9.07)
28 (1.98)

181 (13.67)
998 (75.38)
132 (9.97)
13 (0.98)

7 (0.52)
912 (67.16)
387 (28.50)
52 (3.83)

3 (0.21)
968 (68.75)
418 (29.69)
19 (1.35)

6 (0.45)
988 (74.29)
285 (21.43)
51 (3.83)

9 (0.67)
1028 (77.06)
229 (17.17)
68 (5.10)

0 (0)
978 (76.89)
264 (20.75)
30 (2.36)

1407 (97.44)
37 (2.56)

1392 (97.27)
39 (2.73)

1299 (90.27)
140 (9.73)

1420 (95.88)
61 (4.12)

1346 (96.42)
50 (3.58)

789 (54.64)
655 (45.36)

929 (64.92)
502 (35.08)

1000 (69.49)
439 (30.51)

975 (68.83)
506 (34.17)

968 (69.34)
428 (30.66)
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Notably, the quintiles are largely characterized by country of residence (Table
11). For example, 73% of quintile 1 is comprised of Finland participants and there are no
U.S. participants in this quintile. Quintile 2, on the other hand, includes mostly
participants from Sweden (75%). The distribution of quintile 3 is less extreme with 33%
of participants from Sweden, 13% from Germany, 13% from Finland, and 41% from the
U.S.; however, quintile 4 is almost entirely made up of U.S. participants (90%). Quintile 5
is then basically the opposite of quintile 1 with 72% U.S. participants and very few
participants from Finland (2%). The DQ8/4 allele also has higher prevalence in quintile 1
(the quintile comprised mostly of Finland participants) than the other quintiles. The
quintiles are also largely characterized by residence type, specifically rural residence. No
participants in quintile 1 (the group with the lowest predicted probably of animal
exposure) lived in rural areas. Conversely, 50% of participants in quintile 5 (the group
with the highest predicted probably of animal exposure) lived in rural areas.

Outcome: Persistent, Confirmed IA
No statistically significant associations between early life animal exposure and
persistent, confirmed IA were found for quintiles 2, 3, 4, or 5. This was true even after
directly adjusting for HLA type. Quintile 1, however, did produce a statistically significant
finding. The results indicate that those participants in quintile 1 who were exposed to
animals in early life have a 54% higher risk of developing persistent, confirmed IA than
those participants who were not exposed to animals in early life (HR: 1.54, 95% CI: 1.022.31). Adjusting for HLA type had little impact on the resulting HR (HR: 1.53, 95% CI:
1.02-2.30). These findings are detailed in Table 12. Despite the statistically significant
association identified in the quintile 1 population, a statistically significant difference in
risk of persistent, confirmed IA across the quintiles was not found (p=0.57), indicating no
overall association between early life animal exposure and persistent, confirmed IA .
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Outcome: T1D
No statistically significant associations between early life animal exposure and
T1D were found for any of the propensity score quintiles (Table 13). This was true for all
quintiles even after adjusting for HLA type. Additionally, a statistically significant
difference in risk of T1D across the quintiles was not found (p=0.76).
Table 12: HR & 95% CI for Cox PH Models for Outcome Persistent, Confirmed IA run
within Early Life Animal Exposure Propensity Score Quintiles
Risk of IA by Propensity Score Quintile1
Propensity
Score
Quintile

Exposure Group

Unadjusted Model
HR (95% CI)

Adjusted Model 1
HR (95% CI)

Exposed
1.54 (1.02-2.31)
1.53 (1.02-2.30)
Unexposed
1 (Ref)
1 (Ref)
Exposed
0.79 (0.50-1.24)
0.76 (0.48-1.21)
2
Unexposed
1 (Ref)
1 (Ref)
Exposed
0.86 (0.56-1.34)
0.86 (0.55-1.34)
3
Unexposed
1 (Ref)
1 (Ref)
Exposed
1.35 (0.80-2.26)
1.30 (0.78-2.19)
4
Unexposed
1 (Ref)
1 (Ref)
Exposed
1.12 (0.64-1.97)
1.10 (0.63-1.94)
5
Unexposed
1 (Ref)
1 (Ref)
1
The unadjusted model includes early life animal exposure only (reference group unexposed).
Adjusted model 1 is adjusted for HLA (reference group DQ8/8).
1

Table 13: HR & 95% CI for Cox PH Models for Outcome T1D run within Early Life
Animal Exposure Propensity Score Quintiles
Propensity
Score
Quintile

Exposure Group

Risk of T1D by Propensity Score
Quintile1
Unadjusted Model
Adjusted Model 1
HR (95% CI)
HR (95% CI)

Exposed
1.52 (0.72-3.23)
1.46 (0.69-3.10)
Unexposed
1 (Ref)
1 (Ref)
Exposed
0.35 (0.12-1.04)
0.33 (0.11-0.97)
2
Unexposed
1 (Ref)
1 (Ref)
Exposed
0.97 (0.42-2.27)
0.92 (0.39-2.15)
3
Unexposed
1 (Ref)
1 (Ref)
Exposed
1.48 (0.55-4.02)
1.45 (0.53-3.92)
4
Unexposed
1 (Ref)
1 (Ref)
Exposed
2.10 (0.47-9.31)
2.07 (0.46-9.20)
5
Unexposed
1 (Ref)
1 (Ref)
1
The unadjusted model includes early life animal exposure only (reference group unexposed).
Adjusted model 1 is adjusted for HLA (reference group DQ8/8).
1
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Propensity Score Application 3
Exposed and unexposed participants with propensity scores within 0.1 of one
another were matched as pairs. This resulted in a total of 2,510 matched pairs (5,020
participants). The characteristics of the matched study population for the variables used
to calculate propensity score are detailed in Table 14.

Table 14: Descriptive Statistics of the Matched Study Population for Variables Used in
the Calculation of Propensity Score, N=5,020
Variable

Country of Residence
United States
Finland
Germany
Sweden
Residence Type
Rural Area
Small City/Village
Suburb
Big City
Crowding Space
(Residence Density)
>1 (Crowded)
≤ 1 (Not Crowded)
Mother’s Education Level
Basic Primary Education
Graduated Trade School
Graduated College
Mother Smoked During
Pregnancy
Yes
No
Mother Drank Alcohol
During Pregnancy
Yes
No
Early Life Vaccination
Yes
No
Early Life Social Group
Yes
No

All
N=5,020
N (%)

Exposed to
Animals in
Early Life
N=2,510
N (%)

Not Exposed
to Animals in
Early Life
N=2,510
N (%)

P-value

1886 (37.57)
1030 (20.52)
402 (8.01)
1702 (33.90)

956 (38.09)
511 (20.36)
208 (8.29)
835 (33.27)

930 (37.05)
519 (20.68)
194 (7.73)
867 (34.54)

<0.0001

574 (11.43)
1850 (36.85)
1820 (36.25)
776 (15.46)

302 (12.03)
940 (37.45)
883 (35.18)
385 (15.34)

272 (10.84)
910 (36.25)
937 (37.33)
391 (15.58)

<0.0001

500 (9.96)
4520 (90.04)

246 (9.80)
2264 (90.20)

254 (10.12)
2256 (89.88)

0.0829

1008 (20.08)
1301 (25.92)
2711 (54.00)

529 (21.08)
655 (26.10)
1326 (52.83)

479 (19.08)
646 (25.74)
1385 (55.18)

<0.0001

601 (11.97)
4419 (88.03)

310 (12.35)
2200 (87.65)

291 (11.59)
2219 (88.41)

0.3209

1670 (33.27)
3350 (66.73)

824 (32.83)
1686 (67.17)

846 (33.71)
1664 (66.29)

0.3287

4781 (95.24)
239 (4.76)

2390 (95.22)
120 (4.78)

2391 (95.26)
119 (4.74)

0.4629

3218 (64.10)
1802 (35.90)

1592 (63.43)
918 (36.57)

1626 (64.78)
884 (35.22)

0.2966
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Outcome: Persistent, Confirmed IA
No statistically significant associations between early life animal exposure and
persistent, confirmed IA were found when stratifying by matched pair. This was true
even when directly adjusting for HLA type. These findings are detailed in Table 15.

Outcome: T1D
No statistically significant associations between early life animal exposure and
TID were found when stratifying by matched pair. This was true even when directly
adjusting for HLA type. These findings are detailed in Table 16.

Table 15: HR & 95% CI for Persistent, Confirmed IA, Cox PH Models on Matched Study
Population, N=5,020
Risk of IA for Participants with Early Life Animal Exposure1
Variable

Unadjusted Model
HR (95% CI)

Adjusted Model 1
HR (95% CI)

Early Life Animal
1.02 (0.78-1.32)
0.99 (0.75-1.29)
Exposure
1
The unadjusted model includes early life animal exposure only (reference group unexposed).
Adjusted model 1 is adjusted for HLA (reference group DQ8/8).

Table 16: HR & 95% CI for T1D, Cox PH Models on Matched Study Population, N=5,020
Risk of T1D for Participants with Early Life Animal Exposure1
Variable

Unadjusted Model
HR (95% CI)

Adjusted Model 1
HR (95% CI)

Early Life Animal
0.77 (0.45-1.32)
0.77 (0.44-1.36)
Exposure
1
The unadjusted model includes early life animal exposure only (reference group unexposed).
Adjusted model 1 is adjusted for HLA (reference group DQ8/8).

Additional Analyses
Testing the Proportional Hazards Assumptions
The assumptions of the Cox proportional hazards model were explored and
confirmed. Details of this analysis are provided in Appendix 3.
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Testing for Interactions
The unadjusted Cox proportional hazards models for each outcome (persistent,
confirmed IA and T1D) were run within categories of variables of interest to determine if
there were interactions between the early life animal exposure variable and other
covariates. Variables of interest are those variables included in the final logistic
regression model, as well as HLA which was included in adjusted models. The HR and
corresponding 95% CI for each outcome by variable category are summarized in Table
17. No statistically significant interactions were identified.

Table 17: HR & 95% CI for Unadjusted Cox PH Models run within Variable Categories to
Check for Potential Interactions
Variable

Category

Country of Residence

US
Finland
Germany
Sweden
Rural
Small City/Village
Suburb
Big City
High
Low
Score >1
Score ≤ 1
Quintile 1
Quintile 2
Quintile 3
Quintile 4
Quintile 5
Yes
No
Yes
No
Yes
No
Yes
No
2/2
8/2
8/8
8/4
FDR

Residence Type

Maternal Education
Crowding - Binary
Crowding - Quintiles

Smoking During
Pregnancy
Early Life Vaccination
Early Life Social
Group
Drinking During
Pregnancy
HLA

IA Outcome
HR (95% CI)
0.992 (0.687-1.432)
1.393 (0.955-2.030)
1.032 (0.497-2.141)
0.931 (0.670-1.294)
1.363 (0.756-2.456)
0.775 (0.551-1.088)
1.058 (0.772-1.452)
1.005 (0.594-1.703)
1.075 (0.839-1.377)
0.925 (0.679-1.260)
1.954 (0.978-3.902)
0.925 (0.757-1.132)
1.169 (0.738-1.852)
0.983 (0.635-1.524)
0.877 (0.566-1.360)
0.866 (0.515-1.456)
1.095 (0.75-1.600)
1.221 (0.615-2.423)
0.992 (0.811-1.214)
1.00 (0.823-1.215)
0.662 (0.177-2.478)
1.020 (0.804-1.294)
0.939 (0.676-1.303)
0.856 (0.614-1.194)
1.077 (0.850-1.364)
0.779 (0.455-1.335)
1.021 (0.779-1.339)
1.045 (0.656-1.665)
1.037 (0.635-1.694)
0.714 (0.275-1.850)

T1D Outcome
HR (95% CI)
1.037 (0.498-2.162)
1.311 (0.670-2.562)
1.136 (0.425-3.039)
0.763 (0.354-1.644)
3.243 (0.753-13.973)
0.797 (0.427-1.485)
0.780 (0.412-1.476)
0.939 (0.326-2.707)
0.964 (0.586-1.586)
0.998 (0.571-1.745)
2.070 (0.606-7.075)
0.879 (0.595-1.299)
0.778 (0.365-1.662)
0.944 (0.372-2.395)
0.863 (0.378-1.969)
0.637 (0.227-1.791)
1.518 (0.722-3.190)
1.419 (0.260-7.749)
0.965 (0.661-1.411)
0.978 (0.669-1.429)
0.848 (0.170-4.236)
1.189 (0.732-1.932)
0.737 (0.411-1.320)
0.863 (0.461-1.618)
1.034 (0.655-1.631)
0.680 (0.208-2.230)
0.851 (0.515-1.409)
0.990 (0.347-2.825)
1.865 (0.677-5.133)
0.971 (0.296-3.181)
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Discussion
The purpose of this study was to assess the association between early life
animal exposure and development of T1D, considering two separate endpoints:
persistent, confirmed IA and T1D diagnosis. The relationship between early life animal
exposure and each of these endpoints was assessed utilizing three different propensity
score analysis techniques: model adjustment for propensity score, stratification on
propensity score, and propensity score pair matching. Overall, this study does not
support an association between early life animal exposure and persistent, confirmed IA
or between early life animal exposure and T1D diagnosis. The findings of this study
indicate no significant difference in T1D risk or IA risk among those with early life animal
exposure compared to those without early life animal exposure. These findings were
consistent even when directly adjusted for HLA type.
This study is one of only a few studies that have previously been conducted on
animal exposure and T1D in children and the first we are aware of that examines early
life animal exposure and persistent, confirmed IA. The results of this study are consistent
with the results reported by Radon et al. (19). Radon et al. specifically focused on
regular (at least once per week) contact to stables and T1D diagnosis and examined the
association for those exposed in the first year of life and those exposed in the second to
sixth year of life. Radon et al. did not find a statistically significant association, defined as
p<0.05, between stables (farm animals) exposure and T1D, regardless of age at
exposure. Radon et al. also did not find a statistically significant association between
pets and T1D. The study by Radon et al. differs from the study currently being reported
in that they examined farm animal exposure specifically, included only participants from
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6 to 16 years of age who lived in rural areas of Germany with less than 100,000
residents, and utilized only T1D diagnosis as an endpoint. Additionally, the Radon et al.
study is a case-control study including 242 cases and 224 controls. In comparison, the
study currently being reported is a prospective cohort study including 7,432 participants
enrolled in four different countries without limitation in scope to a particular residence
type (e.g., rural) or particular animal type (e.g., farm animal) and with examination of
both T1D diagnosis and persistent, confirmed IA as endpoints.
The results of this study differ from the results reported by Marshall et al. (17).
Marshall et al. reported a statistically significant protective association between regular
contact with pets/animals and T1D (p=0.045). Their finding was not reproduced in the
study currently being reported. Marshall et al. performed a matched case-control study
including 196 cases and 381 controls consisting of children under the age of 16 years
living in the United Kingdom. It is not clear whether the data used by Marshall et al. to
study the association between animal exposure and T1D was limited to exposure during
a certain period of life, or even if it was limited to exposure prior to T1D diagnosis.
Studying the association between early life animal exposure and development of
T1D in a multinational cohort is an advance for the field of study since previous studies
on animal exposure and T1D have only focused on effects within national populations.
However, studying a population that includes individuals from several countries also
produces challenges. In this study, country appears to be a major factor in animal
exposure propensity. It is possible that attitudes toward pet ownership and animal
contact may differ by country. Koivusilta and Ojanlatva conducted a study on pet
ownership in the Finnish population and found that pet ownership is associated with poor
perceived health among the population (26). This perception could result in pet
avoidance by a parent due to the knowledge of their child being at genetically high risk
for T1D to a greater extent in Finland than in other countries. Finland also differs from
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the other studied countries in that it has the highest incidence of T1D worldwide (5). Of
the countries participating in TEDDY, the country of next highest incidence is Sweden,
followed by the U.S. and then Germany.
The study questionnaires had to be translated to multiple languages in order to
accommodate the multiple countries in the TEDDY study. It is possible that exposure
misclassification could have occurred due to slight differences in these translations that
affect a participant’s understanding of the questions on animal exposure and whether or
not exposure is recorded accurately for how the question was intended. For example,
one of the questions pertaining to animal exposure on the questionnaire is whether the
TEDDY child lives on a farm with animals or if there are animals that live outside of the
child’s house. It is possible, depending how this question translates, that individuals in
some countries may report any animals they encounter that live outside of the child’s
house (regardless of who owns the animal); whereas, individuals in other countries may
only report animals living outside the home that they own. These differences in
interpretation could result in exposure misclassification that may attenuate the HR and
cause concern for the internal validity of the study.
While exposure misclassification cannot be ruled out, outcome misclassification
is unlikely. T1D diagnosis was defined by uniform criteria across sites and was
documented in detail by each of the clinical centers. IA cases were limited to persistent,
confirmed cases only for the purposes of this analysis. This means that an individual
must test positive for IA at two separate consecutive study visits and that these findings
were confirmed by a second laboratory. Considering only persistent, confirmed IA cases
as opposed to all cases of positive IA results limits the likelihood of outcome
misclassification for the IA endpoint.
External validity is limited in this study due to selection bias in regard to a
systematic difference in the characteristics of the individuals selected for the TEDDY
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study compared to the individuals not selected for the TEDDY study. The TEDDY study
is specifically designed to enroll participants who are genetically at high risk for T1D,
which does not accurately represent the general population. A population aware of its
high genetic risk for T1D may have different exposure patterns than a general population
that is not at high risk for T1D or is unaware of its genetic susceptibility to T1D.
Therefore, findings in this study population may not apply to a general population.
An additional disadvantage of the cohort study design is the length of follow-up
needed to obtain a large enough population of those with the outcomes of interest for
analysis. In the present study, there were 113 (2%) participants with T1D and 417 (6%)
participants with persistent, confirmed IA. However, the mean study participant age is
only 4.23 (1.83) years. Study follow-up is intended to continue until age 15 years or T1D
diagnosis, depending on the event that occurs first for each participant. At this time,
power is limited in the ability to detect differences in risk for T1D. Performing this
analysis again in the future after longer follow-up has been completed may elucidate on
how cumulative animal exposure affects risk of T1D. An additional disadvantage
associated with the length of follow-up is the risk for loss to follow-up. To minimize the
effect of loss to follow-up on study analyses, the TEDDY study group has studied
predictors for loss to follow-up in the study population to target individuals at high risk for
loss to follow-up (22). Identifying the individuals at high risk for loss to follow-up allows
clinical centers to take extra care in maintaining contact with these individuals and
encouraging continued participation throughout the course of the study.
Despite the noted limitations, there are several important strengths of the present
study. One strength of the study is the prospective cohort study design. This study
design allows for temporality between the exposure and outcome to be established. In
the TEDDY study, participants are enrolled prior to T1D diagnosis which allows for the
collection of exposure data before diagnosis and ensures temporal sequence. In
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comparison, the other studies on this topic are case-control studies for which temporality
can be questionable since exposure data is collected after diagnosis.
Another advantage of the cohort study design is that it allows for the study of
multiple outcomes. In this case, both persistent, confirmed IA and T1D diagnosis were
studied as outcomes. Furthermore, the prospective cohort study design minimizes recall
bias, which is a major limitation of the other referenced case-control studies on animal
exposures and T1D. Recall bias is a type of measurement bias that is characterized by a
systemic difference in the way cases and controls recall exposures. For example, those
diagnosed with T1D may be more cognizant of exposures they had than those not
diagnosed with T1D, which may cause a difference in the accuracy of the reported
exposures by case status. To minimize this potential bias, the present study limited its
population to individuals diagnosed with persistent, confirmed IA and T1D after 9 months
of age to ensure that exposure data was collected prior to determination of either
outcome. Additionally, the recall of animal exposure in this study was only for a period of
9 months; whereas, the other referenced case-control studies required recall for a period
of many years.
This study is further strengthened by its use of propensity scores and multiple
propensity score techniques. By comparing exposed and unexposed participants with
similar propensity scores, one is simulating a random allocation of treatment. The
propensity score is intended to capture all the background characteristics of the
participant; therefore, if an exposed participant and unexposed participant have the
same propensity score, it is expected that the only difference between these participants
in regard to risk for the endpoint would be the exposure of interest, early life animal
exposure. This simulation of random allocation helps to minimize any selection bias in
regard to differences in the characteristics of the treatment (exposed and unexposed)
groups (27, 28). Initially, propensity score analysis was applied by adjusting for
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propensity score in the Cox proportional hazards models. While this method allows one
to explore the association between early life animal exposure and the endpoints of
interest while controlling for confounding, it does not allow one to explore how
confounding and distribution of variables play a role across the propensity score range.
Therefore, quintiles on propensity score were created in order to further explore the
association in this regard. The third propensity score application, propensity score pair
matching, was pursued in order to define highly matched participants on propensity
score to tease out any effect between early life animal exposure and the outcomes of
interest.
Stratification on propensity score brought to light a few variables that appear to
drive propensity for early life animal exposure, including crowding (residence density),
residence type (e.g., rural), and country of residence. For instance, the group with the
lowest predicted probability of early life animal exposure (quintile 1) included a higher
proportion (17%) of participants living in a crowded environment than the other quintiles.
Furthermore, the group with the lowest propensity for early life animal exposure (quintile
1) included no participants who lived in rural areas; whereas, 50% of the participants in
the group with the highest propensity for early life animal exposure (quintile 5) lived in
rural areas. The most striking difference between quintiles was in regard to the
distribution of country of residence, which largely characterized each quintile. Quintile 1
included mostly participants from Finland (73%), quintile 2 included mostly participants
from Sweden (75%), and quintiles 4 and 5 included mostly participants from the U.S.
(90% and 72% respectively). Quintile 3 was a more heterogeneous population in terms
of country of residence than the other quintiles; however, it still was largely characterized
by participants residing in the U.S. (41%) and Sweden (33%) compared to Germany
(13%) and Finland (13%). These findings emphasized the need for consideration of
potential interactions between early life animal exposure and these variables; however,
50

no significant interactions were found. Further research on the effect of crowding,
residence type, and country of residence on animal exposure, IA, and T1D is warranted.
It was hypothesized that this study would find that children exposed to animals in
early life would have a lower risk of developing IA and T1D than children not exposed to
animals in early life. This hypothesis was based on the idea, rooted in the hygiene
hypothesis, that animals would increase a child’s exposure to organisms that help to
develop appropriate immunoregulation; thus, minimizing the risk of a later immune
system disregulation triggering the development of IA and T1D. The results of this study
do not support the originally stated hypothesis.
While an overall difference in risk of T1D and persistent, confirmed IA by early
life animal exposure status was not found in this study, additional research is needed to
definitively rule out any potential role of animal exposure in the development of T1D.
Suggested research questions include the effect of exposure to different types of
animals, animal exposure duration, primary pet residence (e.g., exposure to family pets
who live inside the home versus exposure to family pets who live outside the home), and
exposure to animals outside the child’s residence (e.g., animals at the zoo, animals the
child visits at another residence) on T1D and IA risk. Studies on animal exposure in
crowded environments are also recommended in order to discern whether the overload
hypothesis, which suggests that individuals who experience an overload of the islet cells
in early life due to characteristics such as physical and psychological stress may result in
accelerated islet autoimmunity and cell death (18, 29), applies to the relationship
between early life animal exposure and T1D development. Additionally, the collection of
data on differences in perceptions of pets across countries could aid the interpretation of
studies on animal exposure and health outcomes.
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Appendix 1
The TEDDY Study Group
Colorado Clinical Center: Marian Rewers, M.D., Ph.D., PI1,4,6,10,11, Katherine Barriga12,
Kimberly Bautista12, Judith Baxter9,12,15, George Eisenbarth, M.D., Ph.D., Nicole Frank2,
Patricia Gesualdo2,6,12,14,15, Michelle Hoffman12,13,14, Lisa Ide, Rachel Karban12, Edwin
Liu, M.D.13, Jill Norris, Ph.D.2,3,12, Kathleen Waugh7,12,15 Adela Samper-Imaz, Andrea
Steck, M.D.3, University of Colorado, Anschutz Medical Campus, Barbara Davis Center
for Childhood Diabetes.
Georgia/Florida Clinical Center: Jin-Xiong She, Ph.D.,PI1,3,4,11,†, Desmond Schatz,
M.D.*4,5,7,8, Diane Hopkins12, Leigh Steed12,13,14,15, Jamie Thomas*6,12, Katherine Silvis2,
Michael Haller, M.D.*14, Meena Shankar*2, Melissa Gardiner, Richard McIndoe, Ph.D.,
Haitao Liu, M.D.†, John Nechtman†, Ashok Sharma, Joshua Williams, Gabriela Foghis,
Stephen W. Anderson, M.D.^ Medical College of Georgia, Georgia Regents University,
*University of Florida, †Jinfiniti Biosciences LLC, Augusta, GA, ^Pediatric Endocrine
Associates, Atlanta, GA.
Germany Clinical Center: Anette G. Ziegler M.D.,PI1,3,4,11, Andreas Beyerlein Ph.D.2,
Ezio Bonifacio Ph.D.*5, Lydia Henneberger2,12, Michael Hummel M.D.13, Sandra
Hummel Ph.D.2, Kristina Foterek¥2, Mathilde Kersting Ph.D.¥2, Annette Knopff7, Sibylle
Koletzko, M.D.¶13, Stephanie Krause, Claudia Peplow12, Maren Pflüger Ph.D.6, Roswith
Roth Ph.D.9, Julia Schenkel2,12, Joanna Stock9,12, Elisabeth Strauss12, Katharina
Warncke M.D.14, Christiane Winkler Ph.D.2,12,15, Forschergruppe Diabetes e.V. at
Helmholtz Zentrum München, *Center for Regenerative Therapies, TU Dresden, ¶Dr. von
Hauner Children´s Hospital,Department of Gastroenterology, Ludwig Maximillians
University Munich, ¥Research Institute for Child Nutrition, Dortmund.
Finland Clinical Center: Olli G. Simell, M.D., Ph.D.,PI¥^1,4,11,13, Heikki Hyöty, M.D.,
Ph.D.*±6, Jorma Ilonen, M.D., Ph.D.¥ ¶3, Mikael Knip, M.D., Ph.D.*±, Maria Lönnrot, M.D.,
Ph.D.*±6, Elina Mantymaki¥^, Juha Mykkänen, Ph.D.^¥ 3, Kirsti Nanto-Salonen, M.D.,
Ph.D.¥ ^12, Tiina Niininen±*12, Mia Nyblom*±, Anne Riikonen*±2, Minna Romo¥^, Barbara
Simell¥^9,12,15, Tuula Simell, Ph.D.¥^9,12, Ville Simell^¥13, Maija Sjöberg¥^12,14, Aino
Steniusµ¤12, Jorma Toppari, M.D., Ph.D., Eeva Varjonen¥^12, Riitta Veijola, M.D., Ph.D.
µ¤14
, Suvi M. Virtanen, M.D., Ph.D.*±§2. ¥University of Turku, *University of Tampere,
µ
University of Oulu, ^Turku University Hospital, ±Tampere University Hospital, ¤Oulu
University Hospital, §National Institute for Health and Welfare, Finland, ¶University of
Kuopio.
Sweden Clinical Center: Åke Lernmark, Ph.D., PI1,3,4,5,6,8,10,11,15, Daniel Agardh, M.D.,
Ph.D.13, Carin Andrén-Aronsson2,13, Maria Ask, Jenny Bremer, Corrado Cilio Ph.D.,
M.D.5, Emilie Ericson-Hallström2, Lina Fransson, Thomas Gard, Joanna Gerardsson,
Gertie Hansson12,14, Monica Hansen, Susanne Hyberg, Fredrik Johansen, Berglind
Jonasdottir M.D., Ulla-Marie Karlsson, Helena Larsson M.D., Ph.D. 6,14, Barbro
Lernmark, Ph.D.9,12, Maria Markan, Theodosia Massadakis, Jessica Melin12, Maria
Månsson-Martinez, Anita Nilsson, Kobra Rahmati, Monica Sedig Järvirova, Sara
Sibthorpe, Birgitta Sjöberg, Ulrica Swartling, Ph.D. 9,12, Erika Trulsson, Carina Törn,
Ph.D. 3,15, Anne Wallin, Åsa Wimar12, Sofie Åberg. Lund University.
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Washington Clinical Center: William A. Hagopian, M.D., Ph.D., PI1,3,4, 5, 6,7,11,13, 14, Xiang
Yan, M.D., Michael Killian6,7,12,13, Claire Cowen Crouch12,14,15, Kristen M. Hay2, Stephen
Ayres, Carissa Adams, Brandi Bratrude, David Coughlin, Greer Fowler, Czarina Franco,
Carla Hammar, Diana Heaney, Patrick Marcus, Arlene Meyer, Denise Mulenga,
Elizabeth Scott, Jennifer Skidmore2, Joshua Stabbert, Viktoria Stepitova, Nancy
Williams. Pacific Northwest Diabetes Research Institute.
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Appendix 2
The TEDDY study forms utilized to collect data on early life animal exposures and T1D
diagnosis are provided on the following pages.
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Appendix 3
The assumptions of the Cox proportional hazards model were explored by
randomly simulating 1000 empirical score processes, based on martingale residuals,
that meet the proportional hazards assumption for the variable early life animal exposure
in regard to each outcome of interest (IA and T1D) and then calculating a p-value
representing the percent of simulated paths that had extreme points that exceeded the
most extreme point of the observed path for the variable of interest. A p-value less than
0.05 would be evidence against the proportional hazards assumption. The resulting pvalues for each predictor variable are summarized in Table A1 for the outcome
persistent, confirmed IA and in Table A2 for the outcome T1D.
All p-values produced by the models for the association between early life animal
exposure and persistent, confirmed IA were greater than the significance level of 0.05;
therefore, the proportional hazards assumption is supported. All p-values produced by
the models for the association between early life animal exposure and T1D were greater
than the significance level of 0.05; therefore, the proportional hazards assumption is
supported.

Table A1: Test for Proportional Hazards Assumption, P-values for each variable included
in model, H0: Hazards Proportional; alpha = 0.05, IA Outcome
Model1
Variable

Unadjusted Model
P-value

Adjusted Model 1
P-value

Adjusted Model 2
P-value

Animal
0.6570
0.6410
0.6470
Exposure
Propensity
0.2250
0.1920
Score
HLA DQ2/2
0.3900
HLA DQ8/2
0.6830
HLA DQ8/4
0.5870
Other HLA
0.7190
1
The unadjusted model includes early life animal exposure only (reference group unexposed).
Adjusted model 1 is adjusted for early life animal exposure propensity score. Adjusted model 2 is
adjusted for propensity score and HLA (reference group DQ8/8).
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Table A2: Test for Proportional Hazards Assumption, P-values for each variable included
in model, H0: Hazards Proportional; alpha = 0.05, T1D Outcome
Model1
Variable

Unadjusted Model
P-value
0.6690

Adjusted Model 1
P-value
0.5230

Adjusted Model 2
P-value
0.5380

Animal
Exposure
Propensity
0.0800
0.0930
Score
HLA DQ2/2
0.5480
HLA DQ8/2
0.5870
HLA DQ8/4
0.2410
Other HLA
0.6760
1
The unadjusted model includes early life animal exposure only (reference group unexposed).
Adjusted model 1 is adjusted for early life animal exposure propensity score. Adjusted model 2 is
adjusted for propensity score and HLA (reference group DQ8/8).

Additionally, the first 20 simulated paths and the actual path for early life animal
exposure were plotted for outcome persistent, confirmed IA (Figure A1) and T1D (Figure
A2). The actual paths do not vary drastically from the simulated paths. This is evidence
in support of the proportional hazards assumption.

Figure A1: Checking Proportional Hazards Assumption for Early Life Animal Exposure
Variable, Outcome Persistent, Confirmed IA, Unadjusted Model
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Figure A2: Checking Proportional Hazards Assumption for Early Life Animal Exposure
Variable, Outcome T1D, Unadjusted Model
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Appendix 4
The Environmental Determinants of Diabetes in the Young (TEDDY) study is approved
by the University of South Florida Institutional Review Board (IRB). The IRB approval for
Callyn Hall, author of this thesis, to conduct analyses on the TEDDY study data is
provided on the following page.
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